FDA declines to approve drug touted by Trump
Digest more
Robert F. Kennedy Jr., the United States Secretary of Health and Human Services, earlier claimed that the drug leucovorin could help treat autism. However, two officials from the U.S. Food and Drug Administration have now dismissed the claim.
The drug leucovorin was touted by the Trump administration in September as a potential treatment for thousands of children with autism. Now, some parents and guardians of children with autism say
Six months ago, the federal government loudly proclaimed the likely benefits of an existing drug called leucovorin for treating autism. Now that proclamation has officially turned into a whimper. On Tuesday,
The Food and Drug Administration on Tuesday approved a generic medication for a rare brain disorder, while walking back statements by President Donald Trump and other administration officials that the drug showed great promise for people with autism.
Aug 20 (Reuters) - The U.S. Food and Drug Administration on Tuesday approved Johnson & Johnson's (JNJ.N), opens new tab chemotherapy-free combination treatment for a type of non-small cell lung cancer, setting up a challenge for AstraZeneca's (AZN.L ...
FDA labeling now recommends DPYD variant testing before initiating capecitabine or 5-FU, except when immediate treatment is clinically necessary. Complete DPD deficiency markedly impairs 5-FU catabolism, increasing risk of early severe diarrhea, mucositis ...
Robert F. Kennedy Jr., the United States Secretary of Health and Human Services, earlier claimed that the drug leucovorin could help treat autism. However, two officials from the U.S. Food and Drug